Key Findings
- Among 10,162 Caris-profiled endometrial cancers, racial survival disparities persisted after molecular classification, with the largest disparity observed in No Specific Molecular Profile tumors.
- This study highlights how genomic, transcriptomic, immune, and biomarker profiling can refine gynecologic cancer subgroups, inform therapeutic development, and reveal clinically relevant differences in treatment response and outcomes.